COVID-19 Not Hypertension or Diabetes Increases the Risk of Preeclampsia among a High-Risk Population

Rachael Morris (), Ahmed S. Z. Moustafa, Wondwosen Kassahun-Yimer, Sarah Novotny, Brittney Billsby, Amira Abbas and Kedra Wallace
Additional contact information
Rachael Morris: Department of Obstetrics & Gynecology, University of Mississippi Medical Center, Jackson, MS 39216, USA
Ahmed S. Z. Moustafa: Department of Obstetrics & Gynecology, University of Mississippi Medical Center, Jackson, MS 39216, USA
Wondwosen Kassahun-Yimer: Department of Data Sciences, University of Mississippi Medical Center, Jackson, MS 39216, USA
Sarah Novotny: Department of Obstetrics & Gynecology, University of Mississippi Medical Center, Jackson, MS 39216, USA
Brittney Billsby: Department of Obstetrics & Gynecology, University of Mississippi Medical Center, Jackson, MS 39216, USA
Amira Abbas: School of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA
Kedra Wallace: Department of Obstetrics & Gynecology, University of Mississippi Medical Center, Jackson, MS 39216, USA

IJERPH, 2022, vol. 19, issue 24, 1-9

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection has been associated with greater morbidity and increased mortality in certain populations, such as those with chronic medical conditions, the elderly, and pregnant women. Our goal was to determine if COVID-19 infection during pregnancy increased the risk of preeclampsia in a population of women with increased risk factors for preeclampsia. We present a prospective observational matched case–control study of 100 deliveries with confirmed SARS-CoV2. Specifically, we investigated the maternal and neonatal outcomes in a high-risk population of pregnant women. Among women with COVID-19, the severity of symptoms was associated with the incidence of preeclampsia, but not with pre-existing diabetes or hypertension. Women with more severe symptoms were more likely to delivery pre-term with smaller babies. After adjusting for diabetes, hypertensive women with COVID-19 had an increased risk of preeclampsia aOR4.3 [1.5,12.4] compared to non-hypertensive women with COVID-19. After adjusting for hypertension, women with diabetes and COVID-19 had an increased risk of preeclampsia aOR3.9 [1.2,12.5]. This relationship was not seen among women without COVID-19. For women who had pre-existing diabetes or hypertension, the risk of developing preeclampsia was only increased if they were also diagnosed with COVID-19, suggesting that in our population of women the risk of preeclampsia is not associated with pre-existing diabetes or hypertension.

Keywords: diabetes; hypertension; obesity; preeclampsia; SARS-CoV2 (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/24/16631/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/24/16631/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:24:p:16631-:d:999880

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().